The European Medicines Agency (EMA) on April 7, 2026, issued a data protection notice outlining how personal data will be processed under the implementation of the Pre-Accession Assistance Programme (IPA). The notice, published by EMA's Data Protection Office, informs stakeholders—including applicants, beneficiaries, and staff involved in IPA activities—about their rights and the agency's obligations under EU data protection law.

Document Context and Type

The notice is a formal data protection notification required under Regulation (EU) 2018/1725, which governs the processing of personal data by EU institutions. It is a mandatory transparency measure, not a policy proposal, and does not introduce new substantive rules. The document specifies the purposes of data processing (e.g., evaluation, monitoring, and reporting of IPA projects), the categories of data collected (e.g., contact details, professional background), and the retention periods.

Policy Orientations and Trade-offs

The notice reflects a balance between transparency and operational efficiency. By detailing data subjects' rights—such as access, rectification, and erasure—the EMA strengthens accountability and aligns with the EU's high data protection standards. However, the administrative burden of compliance may slow down IPA implementation, as project managers must ensure all data processing activities are documented and communicated. This trade-off between data protection and administrative agility is inherent in EU-funded programmes.

Impact on Stakeholders - EU regulatory bodies (EMA): Must allocate resources to maintain compliance, update privacy notices, and handle data subject requests, increasing administrative costs moderately. - Applicants and beneficiaries of IPA funds: Gain clearer rights and transparency on how their data is used, but may face longer processing times for applications due to additional procedural steps. - National authorities in candidate countries: Need to align their data handling practices with EMA's notice when cooperating on IPA projects, potentially requiring training and system adjustments. - EU taxpayers: Benefit from enhanced oversight and accountability of IPA spending, though the added bureaucracy may slightly reduce programme efficiency.

Expected Institutional Follow-up The notice is immediately applicable. EMA will monitor compliance internally and may issue further guidance if data protection issues arise during IPA implementation. The European Commission, which oversees the IPA, may reference this notice in its own data protection policies for similar programmes.

← Atlas › News › Digital & Communication